Toggle navigation
Home
Search
Services
Blog
Contact
About
Second Primary Lung Malignancies Following Breast Cancer
Clarke, E E.
Cancer Care Ontario, Toronto, ON, Canada
Search 6586 grants from E Clarke
Search grants from Cancer Care Ontario
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Dynamic imaging of oscillatory brain networks controlling selective attention
Maternal Lifestyle Study 12-15 Year Follow Up.
Receptor-directed Therapy
Neuromuscular Strategies for Human Tongue Movement
Alveolar Macrophages and Defense of the Lung in AIDS
Recently added grants:
Structure function relationships from deep mutational scanning in human cardiomyopathy
The Human Distal Airway Aging Project
Sleep-disordered breathing in infants with myelomeningocele
Washington University Psychiatry Residency Research Education Program
Targeting Kif11 to Treat Glioblastoma Invasion and Proliferation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Epidemiology And Genetics (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CP061119-003
Application #
2798875
Study Section
Project Start
1996-03-13
Project End
Budget Start
1998-05-12
Budget End
1998-09-12
Support Year
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Cancer Care Ontario
Department
Type
DUNS #
243657665
City
Toronto
State
ON
Country
Canada
Zip Code
M5 2-L7
Related projects
NIH 1998
N01 CP
Second Primary Lung Malignancies Following Breast Cancer
Clarke, E E. / Cancer Care Ontario
NIH 1997
N01 CP
Second Primary Lung Malignancies Following Breast Cancer
Clarke, E E. / Cancer Care Ontario
NIH 1996
N01 CP
Second Primary Lung Malignancies Following Breast Cancer
Clarke, E. / Cancer Care Ontario
Publications
Travis, Lois B; Hill, Deirdre A; Dores, Graca M et al.
(2003)
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
JAMA 290:465-75
Comments
Be the first to comment on this grant